A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Per...

por Dougan, Michael, Azizad, Masoud, Mocherla, Bharat, Gottlieb, Robert L, Chen, Peter, Hebert, Corey, Perry, Russell, Boscia, Joseph, Heller, Barry, Morris, Jason, Crystal, Chad, Igbinadolor, Awawu, Huhn, Gregory, Cardona, Jose, Shawa, Imad, Kumar, Princy, Blomkalns, Andra, Adams, Andrew C, Van Naarden, Jacob, Custer, Kenneth L, Knorr, Jack, Oakley, Gerard, Schade, Andrew E, Holzer, Timothy R, Ebert, Philip J, Higgs, Richard E, Sabo, Janelle, Patel, Dipak R, Dabora, Matan C, Williams, Mark, Klekotka, Paul, Shen, Lei, Skovronsky, Daniel M, Nirula, Ajay
Publicado 2021

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

por Dougan, Michael, Nirula, Ajay, Azizad, Masoud, Mocherla, Bharat, Gottlieb, Robert L., Chen, Peter, Hebert, Corey, Perry, Russell, Boscia, Joseph, Heller, Barry, Morris, Jason, Crystal, Chad, Igbinadolor, Awawu, Huhn, Gregory, Cardona, Jose, Shawa, Imad, Kumar, Princy, Adams, Andrew C., Van Naarden, Jacob, Custer, Kenneth L., Durante, Michael, Oakley, Gerard, Schade, Andrew E., Holzer, Timothy R., Ebert, Philip J., Higgs, Richard E., Kallewaard, Nicole L., Sabo, Janelle, Patel, Dipak R., Dabora, Matan C., Klekotka, Paul, Shen, Lei, Skovronsky, Daniel M.
Publicado 2021